Review ArticleReviewsR
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA and INKA TRESKOVA
Anticancer Research January 2017, 37 (1) 21-33;
JIRI POLIVKA JR.
1Biomedical Center, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic
2Department of Histology and Embryology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic
JIRI POLIVKA
3Department of Neurology, Faculty of Medicine in Plzen, Charles University, Faculty Hospital Plzen, Plzen, Czech Republic
LUBOS HOLUBEC
1Biomedical Center, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic
TEREZA KUBIKOVA
1Biomedical Center, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic
2Department of Histology and Embryology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic
VLADIMIR PRIBAN
4Department of Neurosurgery, Faculty of Medicine in Plzen, Charles University, Czech Republic and Faculty Hospital Plzen, Plzen, Czech Republic
ONDREJ HES
5Department of Pathology, Faculty of Medicine in Plzen, Charles University, and Faculty Hospital Plzen, Plzen, Czech Republic
KRISTYNA PIVOVARCIKOVA
5Department of Pathology, Faculty of Medicine in Plzen, Charles University, and Faculty Hospital Plzen, Plzen, Czech Republic
INKA TRESKOVA
6Department of Surgery, Faculty of Medicine in Plzen, Charles University, and Faculty Hospital Plzen, Plzen, Czech Republic
In this issue
Anticancer Research
Vol. 37, Issue 1
January 2017
Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme
JIRI POLIVKA, JIRI POLIVKA, LUBOS HOLUBEC, TEREZA KUBIKOVA, VLADIMIR PRIBAN, ONDREJ HES, KRISTYNA PIVOVARCIKOVA, INKA TRESKOVA
Anticancer Research Jan 2017, 37 (1) 21-33;
Jump to section
- Article
- Abstract
- Perspectives on Novel Therapies for GBM
- Inhibitors of Growth Factors and Their Receptors, Inhibitors of Intracellular Signaling Pathways
- Inhibition of Angiogenesis in GBM
- Immunotherapy of GBM
- The Role of Immune Checkpoint Inhibitors in Glioblastoma Immunotherapy
- Summary
- Acknowledgements
- Footnotes
- References
- Figures & Data
- Info & Metrics
Related Articles
- No related articles found.
Cited By...
- Suppression of Sleeping Beauty-induced Gliomagenicity in Ts1Cje Mice, a Model of Down Syndrome
- Oncogenic Fusions in Gliomas: An Institutional Experience
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
- Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma
- Investigation of Survivin Gene Polymorphism and Serum Survivin Levels in Patients with Brain Tumors
- Brainstem Glioblastoma Multiforme in a Patient with NF1
- Application of Albumin-embedded Magnetic Nanoheaters for Release of Etoposide in Integrated Chemotherapy and Hyperthermia of U87-MG Glioma Cells
- Expression of FAS-L Differs from Primary to Relapsed Low-grade Gliomas and Predicts Progression-free Survival
- Systemic Intravenous Adoptive Transfer of Autologous Lymphokine-activated {alpha}{beta} T-Cells Improves Temozolomide-induced Lymphopenia in Patients with Glioma